# US Polycystic Ovarian Syndrome Treatment Market 2021 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2024
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-11-29
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: US Polycystic Ovary Syndrome Treatment Market: Latest Trends and Future Forecasts
Meta Description: Discover the latest trends and insights in the US PCOS treatment market. Learn about vertical integration, prevalence of endocrine diseases, and growth
URL: https://financedigest.com/us-polycystic-ovarian-syndrome-treatment-market-2021-global-leading-companies-analysis-revenue-trends-and-forecasts-2024html

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836836209-compressed.jpg)

The [**US Polycystic Ovarian Syndrome Treatment Market Share**](https://www.persistencemarketresearch.com/market-research/us-polycystic-ovarian-syndrome-treatment-market.asp) is expected to witness a **CAGR of 3.9%** between 2024 (reaching **US$ 100 Million**). Vertical integration is the latest trend concerning the healthcare vertical. As such, drug manufacturers, hospital systems, wholesale distributors, PBMs (pharmacy benefit managers), medical [insurers](https://www.financedigest.com/different-countries-different-insurance-cultures-how-insurers-can-adapt-their-products.html "insurers"), and retail pharmacy outlets are into the formation of exclusive synergies all over the healthcare vertical.

[Prevalence of endocrine diseases](https://www.financedigest.com/title-europe-direct-to-consumer-laboratory-testing-market-to-exhibit-26-cagr-by-2031-increasing-geriatric-population-and-growing-prevalence-of-infectious-diseases.html "Europe Direct-to-Consumer Laboratory Testing Market to Exhibit 26% CAGR by 2031; Increasing Geriatric Population and Growing Prevalence of Infectious Diseases") in the US is on a rise as the country’s urban residents continue to bear the brunt of their sedentary lifestyles. Rising incidence of endometriosis, unexplained infertility and polycystic ovarian syndrome (PCOS) [continues to alarm public health authorities across](https://www.financedigest.com/workday-continues-momentum-across-europe.html "Workday continues momentum across Europe") the US. Measures undertaken by non-profit organizations and US [health regulatory bodies are promoting the awareness](https://www.financedigest.com/kids-oral-care-products-market-sale-is-anticipated-to-boost-with-tremendous-growth-by-2030-due-to-health-awareness-of-kids.html "Kids Oral Care Products Market Sale Is Anticipated To Boost With Tremendous Growth By 2030 Due To Health Awareness Of Kids") of PCOS treatments.

Also, therapies for diseases associated with PCOS are being developed to bear out the unmet clinical [needs of people](https://www.financedigest.com/banks-need-to-digitise-financial-wellbeing-support-to-help-young-people-manage-through-this-recession.html "Banks need to digitise financial wellbeing support to help young people manage through this recession") suffering from such complications. Despite this, the demand for PCOS treatment [continues to incur a sluggish growth](https://www.financedigest.com/different-employee-engagement-outcomes-for-u-s-and-canadian-companies-amidst-continued-economic-growth-pressures.html "DIFFERENT EMPLOYEE ENGAGEMENT OUTCOMES FOR U.S. AND CANADIAN COMPANIES AMIDST CONTINUED ECONOMIC GROWTH Pressures") across the US. Persistence [Market Research’s recent publication estimates that the US$ 230 Mn PCOS treatment market in the US will exhibit a moderate value CAGR](https://www.financedigest.com/europe-lithium-ion-battery-market-to-expand-at-a-healthy-cagr-of-around-7-5-over-the-forecast-period-of-2021-2031.html "Europe Lithium Ion Battery Market to expand at a healthy CAGR of around 7.5% over the forecast period of 2021-2031") of 3.9% to reach US$ 313.2 Mn by the end of 2024.

**Get Going With Sample Of Us Polycystic Ovarian Syndrome Treatment Market Report!** [**https://www.persistencemarketresearch.com/samples/14317**](https://www.persistencemarketresearch.com/samples/14317)

The foremost [growth inhibitor for polycystic ovary syndrome treatment market](https://www.financedigest.com/the-uveitis-treatment-market-to-join-the-growth-adsorption-spectrum.html "The Uveitis Treatment Market to join the growth adsorption spectrum") in the US is pending approval of drugs at the FDA. The US FDA continues to prolong the approval for drugs on polycystic ovary [syndrome treatment](https://www.financedigest.com/the-dry-eye-syndrome-treatment-market-to-have-growth-devised-on-innovation.html "The Dry Eye Syndrome Treatment Market to have growth devised on innovation"). And, this has severely lowered the production of effective medicines, thereby [impacting the adoption of PCOS treatment](https://www.financedigest.com/pediatric-hiv-infection-treatment-market-by-covid-19-impact-analysis-volume-and-value-revenue-business-opportunity-future-projections-and-key-trends.html "Pediatric HIV Infection Treatment Market By Covid-19 Impact Analysis – Volume And Value, Revenue, Business Opportunity, Future Projections, And Key Trends"). Presently, no drugs have been approved by the FDA for direct treatment of PCOS. Physicians are thus providing drug prescriptions through off-label indications, which is incidentally diverting patients to [generic drugs](https://www.financedigest.com/generic-oncology-drugs-market-2021-global-leading-companies-analysis-revenue-trends-and-forecasts-2027.html "Generic Oncology Drugs Market 2021 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2027").

Titled as “ **Polycystic Ovary Syndrome Treatment Market: US Industry Analysis and Forecast, 2016-2024**,” the report projects that in 2016, more than US$ 66 Mn worth of oral contraceptive drugs were consumed in the [US polycystic ovary syndrome treatment market](http://www.persistencemarketresearch.com/market-research/us-polycystic-ovarian-syndrome-treatment-market.asp). Through 2024, oral contraceptives will be exhibiting a steady [revenue growth](https://www.financedigest.com/visa-revenue-growth-slows-more-as-tough-economy-sobers-spending.html "Visa revenue growth slows more as tough economy sobers spending") at 5.3% CAGR, and will account for nearly one-third share of market value. Besides, the demand for insulin sensitizing agents is expected to close in on number of oral contraceptives consumed in the US PCOS treatment [market during this forecast](https://www.financedigest.com/commercial-slush-machine-market-comprehensive-shares-historical-trends-and-forecast-by-2028.html "Commercial Slush Machine Market Comprehensive Shares, Historical Trends And Forecast By 2028") period. Furthermore, growing preference to advanced [drugs will also boost](https://www.financedigest.com/astrazeneca-lifts-2022-earnings-outlook-as-cancer-drugs-boost-results.html "AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results") the consumption of aromatase inhibitors & SERMs, revenues from which will reach US$ 49 Mn by 2024-end.

**Get A Customized Scope To Match Your Need Ask An Expert –** [**sales@persistencemarketresearch.com**](mailto:msales@persistencemarketresearch.com)

More than 47% of US polycystic ovary syndrome treatment [market will be accounted by drug sales](https://www.financedigest.com/robotic-vacuum-cleaners-market-to-gain-over-75-of-revenue-from-in-house-robots-sales-fmi.html "Robotic Vacuum Cleaners Market to Gain Over 75% of Revenue from In-house Robots Sales: FMI") through hospital pharmacies. With hospitals as the [largest distribution](https://www.financedigest.com/synechron-partners-with-r3-in-one-of-the-largest-distributed-ledger-consortium-projects-of-the-year.html "Synechron Partners with R3 in One of the Largest Distributed Ledger Consortium Projects of the Year") channel, nearly US$ 150 Mn worth of PCOS drugs will be sold through these pharmacies. Meanwhile, PCOS drug sales through e-commerce platforms are [projected to showcase a value CAGR](https://www.financedigest.com/two-wheeler-accessories-aftermarket-is-projected-to-be-valued-at-us-17-1-bn-in-2021-expanding-at-a-cagr-of-8-6-over-the-forecast-period-of-2021-2031.html "Two Wheeler Accessories Aftermarket is projected to be valued at US$ 17.1 Bn in 2021, expanding at a CAGR of 8.6% over the forecast period of 2021-2031") of 4.6%, higher than that of hospital pharmacies and other distribution channels such as fertility clinics, drug stores and over-the-top counters.

Key companies partaking in the [growth of the US polycystic ovary syndrome treatment market](https://www.financedigest.com/provoked-vestibulodynia-treatment-market-expectations-and-growth-trends-highlighted-until-2028.html "Provoked Vestibulodynia Treatment Market Expectations and Growth Trends Highlighted Until 2028") include Sanofi, Novartis AG, Merck KGaA, Teva Pharmaceutical Industries Limited, and AstraZeneca plc.

**Keeping A Tab On Key Players In The Us Polycystic Ovarian Syndrome Treatment Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Us Polycystic Ovarian Syndrome Treatment Market Report!** [**https://www.persistencemarketresearch.com/checkout/14317**](https://www.persistencemarketresearch.com/checkout/14317)

**About us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact us:**

**Persistence** [Market Research](https://www.financedigest.com/condensed-whey-market-research-report-2022-global-forecast-till-2028.html "Condensed Whey Market Research Report 2022 – Global Forecast till 2028")

Address – 305 Broadway, 7th Floor, New [York City](https://www.financedigest.com/dr-letao-qin-joins-rimon-as-partner-in-its-research-triangle-park-and-new-york-city-offices.html "Dr.Letao Qin, joins Rimon as Partner in its Research Triangle Park and New York City Offices"),

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Sales** – sales@persistencemarketresearch.com


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---